BioTech
The J&J lawsuit should be a wakeup call to the PBM industry — and to companies everywhere
The ongoing legal dispute involving Johnson & Johnson has again thrust the topic of pharmacy benefit managers (PBMs) into the spotlight. Ann Lewandowski, a J&J
Jake Frenz
June 12, 2024